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Favorable course of steroid-responsive nephrotic children with mild
initial attack. The course and prognosis of idiopathic nephrotic syndrome
has thus far not been found to be predicted from the severity of the
manifestations at the onset. Among 66 steroid-responsive nephrotic
children, eight were asymptomatic without edema and identified by chance
proteinuria on a urinary screening program. The selectivity index for
proteinuria (a clearance ratio of JgG to transferrin) was 0.10 or less in all
of the five children examined. All of the eight children responded quickly
to the prednisolone therapy. Grades of proteinuria and hypoalbuminemia
were lower in the asymptomatic children than in the symptomatic children
who presented with edema. Median proteinuria levels were 2.0 versus 4.2
g/day/m2 (P < 0.01), respectively, and mean serum albumin levels were 2.2
0.3 versus 1.8 0.4 g/dl (mean SD; P < 0.01), respectively. None of
the eight asymptomatic children relapsed for at least one year after
completion of the prednisolone treatment, while, in eontrast, 30 of 58
symptomatic nephrotic children relapsed during the same one-year period
(P < 0.01). These findings suggest that, among steroid-responsive ne-
phrotic children, those with mild manifestations without edema may have
a milder disease and show an extremely favorable clinical course.
Children with steroid-responsive nephrotic syndrome follow a
variable course in their disease progression. Approximately one
third of the children will have no subsequent relapses, another
third infrequent relapses and the remaining third will have
frequent relapses following the treatment of ISKDC protocol [1].
It has been demonstrated that a short course of corticosteroid can
still treat some nephrotic children effectively without subsequent
relapses [2] and that the longer the initial corticosteroid is given,
the higher the number of children without relapses [3]. These
findings indicate that levels of severity among children with
steroid-responsive nephrotic syndrome may differ from individual
to individual, Thus far, no clinical or laboratory characteristics at
onset or early in the course of steroid-responsive idiopathic
nephrotic syndrome have been known to predict subsequent
clinical courses following the corticosteroid treatment of the same
protocol, except for the number of relapses in the first six months
[4] and the clinical status at six months after initial treatment [5].
We observed that all of eight asymptomatic steroid-responsive
nephrotic children who were identified by chance proteinuria on a
urinary screening program had an extremely favorable clinical
course.
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Methods
Subjects and results
A total of 72 children were diagnosed as having steroid-
responsive idiopathic nephrotic syndrome in our seven hospitals
from 1983 to 1992, The diagnosis of nephrotic syndrome was
based on the criteria of heavy proteinuria (greater than or equal
to 40 mg/hr/m2 body surface area) and hypoalbuminemia (2.5 g/dl
or less) [2]. Sixty-six of these 72 children were treated with the
prednisolone regimen which was started with daily prednisolone
at doses of 60 mg/day/rn2 in three divided doses for four weeks,
followed by the same doses on an alternate-day regimen which
was gradually tapered over three months [6]. The remaining six
children were treated with the different regimen including high
dose methylprednisolone and were excluded from the present
study. Those whose proteinuria was decreased to less than 4
mg/hr/rn2 during four weeks of the daily prednisolone treatment
were defined as steroid-responsive [1].
Of the 66 children, eight from six hospitals were asymptomatic
and identified by chance proteinuria on a urinary screening
program in their nursery or school. They did not present with
edema at any time from the time of urinary screening to their
admission. Six were boys and two were girls. The median age at
the diagnosis of nephrotic syndrome was 8 years and 2 months
with a range from three to 12 years. All of the eight children had
normal serum creatinine concentration without other systemic
diseases and no hypocomplementemia throughout the course.
Hypertension was noted only in one child, but was observed only
on the day of admission and disappeared the next day. The
selectivity index for proteinuria determined as a clearance ratio of
IgG to transferrin was examined in five children and was 0.10 or
less in all. Two of the eight children also had hematuria and
underwent a histopathological examination of the kidney with the
diagnosis of minimal change nephrotic syndrome (MCNS). While
six of the eight children were diagnosed as having nephrotic
syndrome immediately after the initial visit to our hospital, two
children did not have proteinuria in the nephrotic range or
hypoalbumineniia at the initial visit, and developed nephrotic
range proteinuria and hypoalbuminemia one month or 15 months
later. The time from the initial detection of the proteinuria until
institution of prednisolone treatment ranged from two to 17
months (median 3.5 months).
Daily proteinuria levels, serum albumin and cholesterol levels,
and the incidence of relapses within a year after completion of the
prednisolone treatment were compared between the group of
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Table 1. Comparison of daily proteinuria levels, serum albumin and
cholesterol levels, and incidence of relapses in asymptomatie and
symptomatic nephrotie children
Patients Asymptomatica Symptomati&
No. of cases
Proteinuria g/day/m2C
Serum albumin g/dt'1
Serum cholesterol mg/dt
No. of eases relapsede
8
2.0 (1.4—3.0)
2.2 0.3
343 75
0/8
58
4.2 (l.3_25.6)f
1.8 0.4k
441 114"
30/58 (52%)"
Serum albumin g/dt
1.1—1.5 0/0 11/18(61%)
1.6—2.0 0/2 14/28 (50%)
2.1—2.5 0/6 4/12 (33%)S
Asymptomatie nephrotie children who were identified by chance with
proteinuria through a urinary screening program.
Symptomatic nephrotie children who presented with edema. Data on
proteinuria levels were obtained in 51 of 58 children.
C A median value was shown with a range in parentheses.
A mean value standard deviation were presented.
C Number nf nephrotie children who relapsed within a year after
completion of the initial prednisolone treatment.
Statistical analysis using a Mann-Whitney test or unpaired t-test
showed significant difference between symptomatic and asymptomatie
children (P < 0.01).
Statistical analysis using a goodness test of fit for ehi-square demon-
strated no significant difference in the incidence of relapses among the
three subgroups of nephrotic children with varying serum albumin levels
(P = 0.329).
eight asymptomatic children and the 58 symptomatic children
(Table 1). Daily proteinuria levels at the diagnosis of nephrotic
syndrome were significantly lower in the eight asymptomatic
children than in 51 symptomatic children in whom the data
available (median, 2.0 vs. 4.2 glday/m2, respectively; P < 0.01).
Serum albumin levels were significantly higher in asymptomatic
children than in symptomatic children (mean SD, 2.2 0.3 vs.
1.8 0.4 g/dl, respectively; P < 0.01). Serum cholesterol levels
were lower in asymptomatic children than in symptomatic chil-
dren (mean SD, 343 75 vs. 441 114 mg/dl, respectively; P <
0.01). The mean follow-up period was 5.6 years (range 2.6 to 8.1
years) for asymptomatic children and 5.8 years (range 1.6 to 11.2
years) for symptomatic children. None of the eight asymptomatic
children relapsed for at least one year after completion of the
prednisolone treatment, while, in contrast, 30 of the 58 symptom-
atic children relapsed during the same period (P C 0.01). Among
the symptomatic nephrotic patients, the incidence of relapses
seemed to be a little lower in the subgroup with the higher serum
albumin levels, as shown in Table 1. However, the difference was
not significant. During the two years following the initial treat-
ment, only one (MT) of the eight asymptomatie children relapsed
without edema again, following an insect bite 18 months after the
treatment. Of the four children who were followed for more than
six years, only one child relapsed with faint edema during the
fourth to sixth year after remission. Both of the relapses were
treated with the same prednisolone regimen as the initial one with
a similarly favorable response.
Discussion
It is well known that proteinuria is characteristically more
severe in MCNS than in other glomerular diseases, while prog-
nosis is better in MCNS than in others [7]. In all of the present
cases, proteinuria was not severe so that serum albumin concen-
tration was not low enough to allow any symptoms of nephrotic
syndrome to develop. Through a routine urine screening program,
all of the eight children were identified by chance to have
proteinuria. The milder clinical manifestations in these patients
among nephrotic patients suggest that these children may have
had glomerular diseases other than MCNS. However, none of
these children had hypocomplementemia, and all of the five
children examined had a high selectivity index. All of the children
had normal blood pressure except for one child who was only
transiently hypertensive on admission. It should be noted that all
of the children responded quickly to corticosteroid therapy and
had a favorable prognosis. All of these findings strongly favor the
diagnosis of MCNS in these children, although histopathological
examination was not performed in six of the eight children.
Most children with MCNS have serum albumin concentrations
of 2 g/dl or less [1]. This is consistent with the present study on
symptomatic nephrotic children. On the contrary, most of the
asymptomatic children in the present study had serum albumin
concentrations above 2 g/dl. These asymptomatic nephrotic chil-
dren with mild manifestations might possibly have been in an early
stage of the disease, and some of them might have developed
edema if they had not been identified early by a urinary screening
program and treated with prednisolone. However, a greater
possibility is that these patients might have stable, mild MCNS.
These patients were observed for two to 17 months from the
identification of proteinuria until initiation of prednisolone treat-
ment. Since almost all nephrotic patients with MCNS develop
definite edema very soon, usually within a week after reappear-
ance of proteiouria when they relapse, it is reasonable to conclude
that the children in the present report had mild manifestations
without edema and had a mild form of MCNS. All of these
children with mild manifestations had no relapse for at least one
year after the treatment. This fact is notable since a half of the
symptomatic nephrotic children who presented with edema in our
hospitals were found to relapse within one year after the treat-
ment. These findings suggest that among the steroid-responsive
nephrotic children, who most probably have MCNS, those with
mild manifestations without edema have a good clinical course
without frequent relapsing.
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